United States· US:0924-0159_26821d65-9e6e-b5ed-e063-6394a90a5166
Eyewash Station Additive Concentrate
A medicinal product containing chlorhexidine gluconate; propylene glycol, registered in United States by Acme United Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL
- Manufacturer
- Acme United Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110924015908.236 L in 1 BOTTLE, UNIT-DOSE (0924-0159-08)
- ndc110924-0159-08
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b554fc97-a2de-4d35-803c-c657cd1a6946 GET /v1/drugs/b554fc97-a2de-4d35-803c-c657cd1a6946?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "145.6; 280",
"substance": "CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL",
"productndc": "0924-0159",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "kg/2800L; kg/2800L",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about chlorhexidine gluconate; propylene glycol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.